Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2001 May;67(5) > Minerva Anestesiologica 2001 May;67(5):381-5



A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

Frequency: Monthly

ISSN 0375-9393

Online ISSN 1827-1596


Minerva Anestesiologica 2001 May;67(5):381-5



Thromboembolism in pregnancy: a new temporary caval filter

Ferraro F., D’Ignazio N., Matarazzo A. *, Rusciano G., Iannuzzi M., Belluomo Anello C.

From the Sec­on­da ­Università ­degli Stu­di - Nap­o­li Dipar­ti­men­to di Anes­te­sia e Rian­i­maz­i­one Ser­vi­zio di Tera­pia Inten­si­va
*Cat­te­dra di Chi­rur­gia Vas­co­lare S.U.N.

Back­ground. Our aim was to ­check out the advan­tag­es of tem­po­rary ­caval fil­tra­tion in preg­nan­cy ­with a retriev­able fil­ter: Tem­po­fil­ter™ (tCF).
Meth­ods. Dur­ing a peri­od of 2 ­years we implant­ed tCF in ­four ­patients at the ­third preg­nan­cy tri­mes­ter ­with seri­ous ­acute ­deep ­venous throm­bo­sis (DVT) of the low­er ­limbs for pro­phy­lax­is of pul­mo­nary throm­boem­bol­ic dis­ease (TED) in the pre-par­tum, dur­ing Cae­sar­ian sec­tion (CS), and in the ­post-par­tum peri­od. tCF has ­been ­placed per­cut­ane­ous­ly in ­local anaesthe­sia ­using the Sel­ding­er tech­nique and ­under ­image inten­si­fi­er con­trol. All pro­ce­dures ­were per­formed in a poly­va­lent ICU.
­Results. tCF posi­tion­ing was ­always ­easy. No com­pli­ca­tions ­linked to the adopt­ed tech­nique ­occurred. No inci­dence of pul­mo­nary embo­lism was report­ed (PE). The per­ma­nence peri­od of tCF in ­situ was 14 to 29 ­days (­mean±SD: 21±6). The CS ­always ­took ­place with­out com­pli­ca­tions ­either for the ­patient or for the foe­tus.
Con­clu­sions. The com­bined use of tCF and an ­anti-coag­u­lat­ing ther­a­py result­ed in an effec­tive pro­phy­lax­is of TED for the preg­nant wom­an with­out any inter­fer­enc­es ­with CS and ­with no con­se­quence as for per­ma­nent endo­vas­cu­lar pros­the­sis for the ­young ­patient her­self.

language: English


top of page